| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2004-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2004-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2004-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2004-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-72 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G45-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B05D7-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2013-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105188772-B |
| titleOfInvention |
T1-T2 Dual Mode MRI Contrast Agent Based on Metal Oxide Nanoparticles |
| abstract |
The present invention relates to a magnetic resonance imaging (MRI) contrast agent, in particular a T1-T2 dual-mode MRI contrast agent based on metal oxide nanoparticles, and a method for producing said MRI contrast agent, which MRI contrast agent Not only can be used as T1 MRI contrast agent, but also can be used as T2 MRI contrast agent. Through the favorable contrast effect between T1 imaging with high tissue resolution and T2 imaging with high feasibility of detecting lesions, metal oxide nanoparticle-based T1‑T2 dual-modal MRI contrast agents can provide better results than single MRI imaging. Contrast agents provide more precise and detailed disease-related information. |
| priorityDate |
2013-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |